Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Pfizer and Medicines for Malaria Venture have signed an agreement that gives MMV access to Pfizer's library of novel chemical entities. Under the deal, scientists in institutes affiliated with MMV will test about 200,000 Pfizer compounds against Plasmodium falciparum, the parasite that causes malaria. The screening will take place at the Eskitis Institute for Cell & Molecular Therapies at Griffith University, in Australia.
This article has been sent to the following recipient: